IVD Medical Holding Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für IVD Medical Holding zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum	21.1%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Oct 14

Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

Sep 27

IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

Aug 17

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

Jun 07

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

May 22

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 25

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 03

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

Mar 30

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Mar 20

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

Mar 06

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Feb 08

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 05

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Mar 22

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Feb 16

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Oct 16

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Sep 28

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

May 16

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

Apr 14

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 23

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Mar 16

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

Jul 30

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well

May 04

There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital

Apr 20

IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year

Mar 05

Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 15

Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like

Jan 31

A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Jan 16

Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?

Jan 01

How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?

Dec 17

Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?

Dec 02

IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.

Nov 19

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da IVD Medical Holding jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

SEHK:1931 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2024	3,065	260	127	165	N/A
3/31/2024	3,076	249	190	229	N/A
12/31/2023	3,088	238	252	292	N/A
9/30/2023	3,019	235	345	387	N/A
6/30/2023	2,950	232	438	481	N/A
3/31/2023	2,849	221	327	366	N/A
12/31/2022	2,749	210	215	250	N/A
9/30/2022	2,735	193	118	146	N/A
6/30/2022	2,720	177	21	42	N/A
3/31/2022	2,726	176	80	103	N/A
12/31/2021	2,731	175	138	163	N/A
9/30/2021	2,682	187	266	293	N/A
6/30/2021	2,634	199	394	423	N/A
3/31/2021	2,531	179	270	297	N/A
12/31/2020	2,428	159	145	170	N/A
9/30/2020	2,415	87	N/A	N/A	N/A
6/30/2020	2,401	15	60	92	N/A
3/31/2020	2,367	145	185	216	N/A
12/31/2019	2,333	275	310	341	N/A
9/30/2019	1,757	321	N/A	N/A	N/A
6/30/2019	1,156	366	8	28	N/A
3/31/2019	785	235	-3	15	N/A
12/31/2018	414	103	-14	2	N/A
9/30/2018	387	114	7	25	N/A
12/31/2017	338	111	N/A	20	N/A
12/31/2016	290	56	N/A	-24	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von 1931 über der Sparquote liegt (2.3%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von 1931 schneller wachsen werden als der Markt Hong Kong

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von 1931 in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von 1931 schneller wachsen werden als der Markt von Hong Kong.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von 1931 schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von 1931 in 3 Jahren voraussichtlich hoch sein wird

IVD Medical Holding Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

IVD Medical Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2021

Recent updates

Investor sentiment deteriorates as stock falls 18%

IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up

Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings

Investor sentiment improves as stock rises 43%

First half 2024 earnings released: EPS: CN¥0.093 (vs CN¥0.076 in 1H 2023)

IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings

IVD Medical Holding Limited to Report First Half, 2024 Results on Aug 28, 2024

New minor risk - Shareholder dilution

Upcoming dividend of HK$0.062 per share

Investor sentiment deteriorates as stock falls 17%

Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding

New major risk - Share price stability

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely

Investor sentiment deteriorates as stock falls 16%

Investor sentiment deteriorates as stock falls 17%

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

New minor risk - Share price stability

IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings

IVD Medical Holding Limited Appoints Law Kim Fai as Chief Financial Officer

Investor sentiment improves as stock rises 15%

IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year

Full year 2023 earnings released: EPS: CN¥0.18 (vs CN¥0.16 in FY 2022)

IVD Medical Holding Limited, Annual General Meeting, May 16, 2024

IVD Medical Holding Limited Announces Executive Changes

If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity

IVD Medical Holding Limited to Report Q4, 2023 Results on Mar 15, 2024

Investor sentiment improves as stock rises 25%

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

IVD Medical Holding Limited Announces Resignation of Sun Tao as a Non-Executive Director

Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)

Investor sentiment improves as stock rises 16%

Now 25% undervalued

IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher

Investor sentiment improves as stock rises 22%

Upcoming dividend of HK$0.03 per share at 7.1% yield

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297

IVD Medical Holding Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on September 13, 2023

First half 2023 earnings released: EPS: CN¥0.076 (vs CN¥0.061 in 1H 2022)

IVD Medical Holding Limited Declares the Payment of an Interim Dividend for the Six Months Ended 30 June 2023, Expected to Be Paid on 6 September 2023

IVD Medical Holding Limited Announces Board Changes

IVD Medical Holding Limited to Report First Half, 2023 Results on Aug 18, 2023

Upcoming dividend of HK$0.056 per share at 5.2% yield

Investor sentiment improves as stock rises 15%

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556

Full year 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.13 in FY 2021)

Investor sentiment deteriorates as stock falls 20%

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 20%

Returns At IVD Medical Holding (HKG:1931) Are On The Way Up

Less than half of directors are independent

Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?

Investor sentiment deteriorated over the past week

Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)

Upcoming dividend of HK$0.027 per share

IVD Medical Holding Limited Declares Interim Dividend for the Six Months Ended June 30, 2022, Payable on 19 September 2022

First half 2022 earnings released: EPS: CN¥0.061 (vs CN¥0.06 in 1H 2021)

Investor sentiment improved over the past week

Upcoming dividend of HK$0.053 per share

IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet

Less than half of directors are independent

IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053

IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year

IVD Medical Holding Limited, Annual General Meeting, May 20, 2022

IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price

Upcoming dividend of HK$0.027 per share

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.029 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.029 in 1H 2020)

IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital

IVD Medical Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2021

IVD Medical Holding Limited Approves Final Dividend for the Year Ended 31 December 2020

Upcoming dividend of HK$0.036 per share

These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well